SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
Study Number: 

I 247913

Phase: 
Early Phase
Principal Investigator: